Vaishali Pharma Limited (VAISHALI.NS)
INR 19.0
(0.42%)
INR 19.0
(0.42%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 862.79 Million | 696.62 Million | 715.36 Million | 523.07 Million | 584.11 Million | 724.55 Million |
| Cost of Revenue | 772.47 Million | 546.77 Million | 635 Million | 461.51 Million | 510.89 Million | 686.62 Million |
| Gross Profit | 90.32 Million | 149.85 Million | 80.36 Million | 61.56 Million | 73.22 Million | 37.93 Million |
| Operating Expenses | 84.02 Million | 63.6 Million | 16.07 Million | 21.14 Million | 26.92 Million | 20.04 Million |
| Selling, General and Administrative Expenses | 84.02 Million | 9.06 Million | 30.91 Million | 11.44 Million | 14.17 Million | 13.38 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 22.28 Million | 473.43 Thousand | 1.52 Million | 12.75 Million | 96.34 Thousand |
| Cost and Expenses | 856.5 Million | 610.37 Million | 651.07 Million | 482.65 Million | 537.81 Million | 706.66 Million |
| Operating Income | 6.29 Million | 88.73 Million | 64.29 Million | 22.21 Million | 4.62 Million | 17.89 Million |
| Interest Expense | 22.67 Million | 20.08 Million | 24.88 Million | 26.25 Million | 25.56 Million | 26.37 Million |
| Income Tax Expense | 2.07 Million | 22.42 Million | 17.04 Million | 3.58 Million | 463.21 Thousand | 4.18 Million |
| Earnings before Tax | 9.26 Million | 88.45 Million | 57.28 Million | 14.04 Million | 791.05 Thousand | 11.32 Million |
| Net Income | 7.18 Million | 66.03 Million | 40.23 Million | 10.46 Million | 327.84 Thousand | 7.13 Million |
| Earnings Per Share Basic | 0.68 | 6.26 | 3.82 | 0.99 | 0.03 | 0.68 |
| Earnings Per Share Diluted | 0.64 | 5.91 | 3.82 | 0.99 | 0.03 | 0.68 |
| Weighted Average Shares Outstanding | 10.61 Million | 11.17 Million | 10.54 Million | 10.54 Million | 10.54 Million | 10.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.23 Million | 11.17 Million | 10.54 Million | 10.54 Million | 10.54 Million | 10.54 Million |
| Gross Margin | 0.10 | 0.22 | 0.11 | 0.12 | 0.13 | 0.05 |
| EBIT Margin | 0.04 | 0.16 | 0.12 | 0.12 | 0.12 | 0.06 |
| Profit Margin | 0.01 | 0.09 | 0.06 | 0.02 | 0.00 | 0.01 |
| EBITDA | 31.71 Million | 113.59 Million | 86.43 Million | 44.42 Million | 29.99 Million | 40.4 Million |
| Earnings Before Tax Margin | 0.01 | 0.13 | 0.09 | 0.04 | 0.01 | 0.02 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 180.79 Million | 323.96 Million | 862.79 Million | 278.95 Million | 125.65 Million | 134.22 Million |
| Cost of Revenue | 151.97 Million | 330.86 Million | 772.47 Million | 246.17 Million | 82.5 Million | 99.22 Million |
| Gross Profit | 28.82 Million | -6.9 Million | 90.32 Million | 32.78 Million | 43.15 Million | 34.99 Million |
| Operating Expenses | 6.57 Million | 62.31 Million | 84.02 Million | 4.49 Million | 17.82 Million | 13.11 Million |
| Selling, General and Administrative Expenses | 6.57 Million | 62.31 Million | - | 4.49 Million | 10.7 Million | 5.39 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 4.24 Million | - | 3.83 Million | 4.69 Million | 2.97 Million | 3.6 Million |
| Cost and Expenses | 158.55 Million | 393.17 Million | 856.5 Million | 250.66 Million | 100.32 Million | 112.33 Million |
| Operating Income | 22.24 Million | -69.21 Million | 6.29 Million | 28.28 Million | 28.31 Million | 21.88 Million |
| Interest Expense | 3.79 Million | 4 Million | 22.67 Million | 4.34 Million | 4.71 Million | 4.3 Million |
| Income Tax Expense | 5.71 Million | -17.33 Million | 2.07 Million | 7.51 Million | 6.56 Million | 5.33 Million |
| Earnings before Tax | 22.7 Million | -64.16 Million | 9.26 Million | 28.63 Million | 23.59 Million | 21.19 Million |
| Net Income | 16.99 Million | -46.82 Million | 7.18 Million | 21.11 Million | 17.03 Million | 15.85 Million |
| Earnings Per Share Basic | 1.40 | -4.37 | - | 1.99 | 1.61 | 1.50 |
| Earnings Per Share Diluted | 1.38 | -4.37 | - | 1.89 | 1.52 | 1.41 |
| Weighted Average Shares Outstanding | 12.09 Million | 10.71 Million | 10.61 Million | 10.59 Million | 11.2 Million | 11.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.31 Million | 10.71 Million | 10.61 Million | 11.17 Million | 11.2 Million | 11.24 Million |
| Gross Margin | 0.16 | -0.02 | 0.10 | 0.12 | 0.34 | 0.26 |
| EBIT Margin | 0.13 | -0.21 | - | 0.11 | 0.24 | 0.20 |
| Profit Margin | 0.09 | -0.14 | 0.01 | 0.08 | 0.14 | 0.12 |
| EBITDA | 23.44 Million | -67.8 Million | - | 29.52 Million | 29.54 Million | 26.69 Million |
| Earnings Before Tax Margin | 0.12 | -0.21 | 0.01 | 0.10 | 0.23 | 0.16 |
4303
AEGOF
ASIANENE
3303
RITES
CBWBF